|
There's a new way to reduce consulting costs-and develop in-house intellectual capital at the same time.
Feb 1, 2002
By:
Stan Bernard, MD
It's time for the big project. Top management in a leading pharma company wants executive A, a rising star in the marketing department, to evaluate a new technology's impact on the industry-and on his company. The technology has the potential to dramatically affect not only pharmaceutical discovery and development but also marketing and sales. But there are many factors to analyze, and no one in his company has the expertise to do it.
|
PharmExec Blog
Follow Us
RSS
Bookstore
